LOGOLOGOLOGOLOGO
  • About us
    • What we do
    • Who we are
      • Governance
      • Staff
      • Vacancies
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Patient BioForum
      • Study – Impact of the EU’s General Pharmaceutical Legislation
    • Industrial Biotechnology Council
      • EFIB
      • Microorganisms
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
      • Biotechnology in our Lives
  • Activities
    • 25 Years of Innovation
    • The EU Biotech Act
    • European Biotech Week
    • EU Projects
      • PRIMED Project
      • APROVALS Project
  • News & Events
    • News
    • Events
  • Library
Become a member
✕

Ajinomoto Europe joins EuropaBio: unlocking the power of amino acids

24/05/2023

NEWS RELEASE

Brussels, 24 May 2023 - EuropaBio is pleased to announce that Ajinomoto Europe has joined as a corporate member.

The Ajinomoto Group is a leading global food and bioscience company committed to improving the health and well-being of people through its know-how in “AminoScience”. With a diverse portfolio covering amino acids, specialty chemicals, food ingredients and consumer food products, the Ajinomoto Group combines innovation and sustainability to address diverse consumer needs globally. The company's mission is to contribute to significant advancements in health, nutrition, and the environment.

EuropaBio Director-General Dr. Claire Skentelbery said: “We are delighted to bring Ajinomoto into the EuropaBio community. Its membership reflects the significance of industrial biotechnology and biomanufacturing for a global Europe”.

Mr. Keng Ngee Teoh, Manager for Regulatory Science and Quality Assurance of Ajinomoto Europe added: “As a science-driven company founded in Japan, we hope to contribute our knowledge and expertise to support the advancement of the bioeconomy in Europe. As the leading voice of the bioscience industry in Europe, we are confident that EuropaBio will provide us a platform to do so”.

Ajinomoto Europe joins EuropaBio: unlocking the power of amino acids


Download
Share
Francesca Degli Agostini
Francesca Degli Agostini

Related posts

22/05/2025

Adisseo joins EuropaBio: Feeding Animals Sustainably Around the World


Read more
21/05/2025

Ensuring Biotech Integration in the Single Market


Read more
10/04/2025

EU biotechnology competitiveness for the future; high level dialogue with EVP Séjourné


Read more

Important links

  • Adisseo joins EuropaBio: Feeding Animals Sustainably Around the World
  • Ensuring Biotech Integration in the Single Market

Categories in our Newsroom

EBIO-white

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2025 Europabio. All Rights Reserved. Designed by EYAS
Become a member

Algal Omega 3

Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

Cheese

Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.

Clothes

Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

Vitamin B2

The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

Detergents

Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

Insulin

Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.